Enzymatica Publ (Sweden) Market Value

ENZY Stock  SEK 1.77  0.03  1.67%   
Enzymatica Publ's market value is the price at which a share of Enzymatica Publ trades on a public exchange. It measures the collective expectations of Enzymatica publ AB investors about its performance. Enzymatica Publ is selling for under 1.77 as of the 26th of November 2024; that is 1.67 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.73.
With this module, you can estimate the performance of a buy and hold strategy of Enzymatica publ AB and determine expected loss or profit from investing in Enzymatica Publ over a given investment horizon. Check out Enzymatica Publ Correlation, Enzymatica Publ Volatility and Enzymatica Publ Alpha and Beta module to complement your research on Enzymatica Publ.
Symbol

Please note, there is a significant difference between Enzymatica Publ's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzymatica Publ is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzymatica Publ's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Enzymatica Publ 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enzymatica Publ's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enzymatica Publ.
0.00
01/06/2023
No Change 0.00  0.0 
In 1 year 10 months and 22 days
11/26/2024
0.00
If you would invest  0.00  in Enzymatica Publ on January 6, 2023 and sell it all today you would earn a total of 0.00 from holding Enzymatica publ AB or generate 0.0% return on investment in Enzymatica Publ over 690 days. Enzymatica Publ is related to or competes with Oncopeptides, Diamyd Medical, Kancera AB, Bonesupport Holding, and Cantargia. Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and i... More

Enzymatica Publ Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enzymatica Publ's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enzymatica publ AB upside and downside potential and time the market with a certain degree of confidence.

Enzymatica Publ Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Enzymatica Publ's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enzymatica Publ's standard deviation. In reality, there are many statistical measures that can use Enzymatica Publ historical prices to predict the future Enzymatica Publ's volatility.
Hype
Prediction
LowEstimatedHigh
0.091.775.90
Details
Intrinsic
Valuation
LowRealHigh
0.081.595.72
Details

Enzymatica publ AB Backtested Returns

Enzymatica publ AB secures Sharpe Ratio (or Efficiency) of -0.0168, which denotes the company had a -0.0168% return per unit of risk over the last 3 months. Enzymatica publ AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enzymatica Publ's Mean Deviation of 2.84, standard deviation of 4.77, and Variance of 22.72 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.79, which means possible diversification benefits within a given portfolio. As returns on the market increase, Enzymatica Publ's returns are expected to increase less than the market. However, during the bear market, the loss of holding Enzymatica Publ is expected to be smaller as well. At this point, Enzymatica publ AB has a negative expected return of -0.0692%. Please make sure to confirm Enzymatica Publ's skewness, rate of daily change, price action indicator, as well as the relationship between the accumulation distribution and day typical price , to decide if Enzymatica publ AB performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.02  

Virtually no predictability

Enzymatica publ AB has virtually no predictability. Overlapping area represents the amount of predictability between Enzymatica Publ time series from 6th of January 2023 to 17th of December 2023 and 17th of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enzymatica publ AB price movement. The serial correlation of 0.02 indicates that only 2.0% of current Enzymatica Publ price fluctuation can be explain by its past prices.
Correlation Coefficient0.02
Spearman Rank Test-0.12
Residual Average0.0
Price Variance0.45

Enzymatica publ AB lagged returns against current returns

Autocorrelation, which is Enzymatica Publ stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enzymatica Publ's stock expected returns. We can calculate the autocorrelation of Enzymatica Publ returns to help us make a trade decision. For example, suppose you find that Enzymatica Publ has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Enzymatica Publ regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enzymatica Publ stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enzymatica Publ stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enzymatica Publ stock over time.
   Current vs Lagged Prices   
       Timeline  

Enzymatica Publ Lagged Returns

When evaluating Enzymatica Publ's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enzymatica Publ stock have on its future price. Enzymatica Publ autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enzymatica Publ autocorrelation shows the relationship between Enzymatica Publ stock current value and its past values and can show if there is a momentum factor associated with investing in Enzymatica publ AB.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Enzymatica Stock Analysis

When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.